Novartis Vaccines and Diagnostics GmbH
Novartis Vaccines and Diagnostics GmbH, a prominent player in the biopharmaceutical industry, is headquartered in Germany (DE) and operates extensively across Europe and North America. Founded in 2006, the company has made significant strides in vaccine development and diagnostics, focusing on innovative solutions to combat infectious diseases.
Specialising in vaccines and diagnostic tools, Novartis Vaccines is renowned for its commitment to research and development, which has led to the creation of unique products that address critical health challenges. The company has achieved notable milestones, including advancements in vaccine technology and strategic partnerships that enhance its market position.
With a strong emphasis on quality and efficacy, Novartis Vaccines and Diagnostics GmbH continues to be a leader in the healthcare sector, contributing to global health initiatives and improving patient outcomes worldwide.
+62 vs industry average
Novartis Vaccines and Diagnostics GmbH’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Novartis Vaccines and Diagnostics GmbH?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Novartis Vaccines and Diagnostics GmbH yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Novartis Vaccines and Diagnostics GmbH’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Novartis Vaccines and Diagnostics GmbH yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novartis AG
Carbon Disclosure Project
Inherited from Novartis AGThe Climate Pledge
Inherited from Novartis AGUN Global Compact Climate Champions initiative
RE 100
Inherited from Novartis AGClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project